Turmeric Supplements Show Little Benefit for Knee Osteoarthritis; Safety Uncertain

A major Cochrane review published this week finds turmeric supplements offer little to no meaningful improvement in pain, function, or quality of life for people with knee osteoarthritis compared to placebo, though a small increase in treatment success was observed. The evidence on safety remains very uncertain, with reviewers unable to determine whether the supplements cause more unwanted events than a dummy treatment.

The analysis, published by the Cochrane Library, pooled data from nine randomized controlled trials involving 1,245 participants, all of whom had knee osteoarthritis. Four studies with 379 participants directly compared turmeric supplements taken by mouth to a placebo over periods ranging from four weeks to three months.

On a zero-to-10 pain scale, participants taking turmeric reported a 2.29-point reduction in pain versus a 1.57-point reduction for those on placebo — a difference of 0.72 points. On a zero-to-100 function scale, the turmeric group improved by 8.92 points compared to 5.42 points for placebo, a difference of 3.5 points.

Quality of life, measured on a similar 100-point scale, improved by 12.02 points with turmeric versus 9.83 points with placebo, a difference of 2.19 points. Reviewers characterized all three differences as little to no improvement.

Treatment success, defined as participants rating their treatment as successful, showed a modest gain: 84 more people per 1,000 reported success with turmeric than with placebo, based on two studies totalling 170 participants.

Regarding safety, the review states, “We do not know if turmeric leads to more unwanted events (any type and serious events)” and “more people leaving the studies due to unwanted events.” The certainty of evidence for these outcomes was rated as very low across four studies involving 379 people and three studies involving 321 people, respectively.

All participants in the analyzed trials had knee osteoarthritis; the review notes that future studies should include people with hand and hip osteoarthritis. The studies were conducted in Australia, Belgium, India, and Thailand, with participants averaging 52 to 62 years old and two-thirds being female.

The review also identified trials comparing turmeric to anti-inflammatory pain medicines such as ibuprofen or diclofenac and to paracetamol, but the published summary reports detailed results only for the placebo comparison.

Photo of author

Health Desk

Health Desk at Archyde.

Trump Meets Xi at APEC Summit in Shenzhen Before Putin Trilateral